# Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali

> **NCT02784743** · PHASE4 · COMPLETED · sponsor: **Centre d'Appui à la lutte contre la Maladie** · enrollment: 1139 (actual)

## Conditions studied

- Lymphatic Filariasis

## Interventions

- **DRUG:** ''albendazole'' and ''ivermectin''

## Key facts

- **NCT ID:** NCT02784743
- **Lead sponsor:** Centre d'Appui à la lutte contre la Maladie
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** 2008-12
- **Final completion:** 2015-04
- **Target enrollment:** 1139 (ACTUAL)
- **Last updated:** 2016-05-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02784743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02784743, "Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02784743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*